Precision medicine in the first-line treatment of EGFR-mutated non-small cell lung cancer: moving beyond “one-size-fits-all”

Ikushima, Hiroaki; Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, Kage, Hidenori; Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
ISSN / E-ISSN
— / —
DOI
10.21037/tlcr-2026-1-0223 ↗
Volume · Issue · Pages
15 · 4 · —
Publisher
AME Publishing Company
Article URL
https://tlcr.amegroups.org/article/view/116525 ↗
Article details
Unverified
Publication date (each date has its type and source)
30 Apr 2026
Publisher publication date · source: Journal websites (OAI-PMH feeds of Open Journal Systems)
Dates on record for this article
TypeDateSource
Publisher publication date30 Apr 2026 Journal websites (OAI-PMH feeds of Open Journal Systems)

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: Dataset incomplete or not yet confirmed as complete: we cannot say whether the journal was listed. This is not a derecognition.
Journal
Translational Lung Cancer Research
Publication date used
30 Apr 2026 (Publisher publication date)
Applicable HEC period
HEC 2026-27 (version 1) · 01 Apr 2026 – 31 Dec 2027
Category
—
Recognition status
Pending Verification (PERIOD_NOT_CERTIFIED)
Source
—
Verification status
Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.